ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00950300
Brief Title: A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer

First Submitted : July 30, 2009
First Submitted that Met QC Criteria : July 30, 2009
First Posted : July 31, 2009 (Estimate)

Results First Submitted : November 4, 2016
Results First Submitted that Met QC Criteria : November 22, 2016
Results First Posted : January 23, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : December 21, 2017
Last Update Posted : January 23, 2018